CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 53 filers reported holding CORVUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,145 | +151.6% | 500,000 | 0.0% | 0.04% | +29.6% |
Q1 2023 | $455 | +7.1% | 500,000 | 0.0% | 0.03% | +12.5% |
Q4 2022 | $425 | -99.9% | 500,000 | 0.0% | 0.02% | +41.2% |
Q3 2022 | $409,000 | -17.4% | 500,000 | 0.0% | 0.02% | -34.6% |
Q2 2022 | $495,000 | -39.6% | 500,000 | 0.0% | 0.03% | -23.5% |
Q1 2022 | $820,000 | -32.0% | 500,000 | 0.0% | 0.03% | +3.0% |
Q4 2021 | $1,205,000 | -50.2% | 500,000 | 0.0% | 0.03% | -38.9% |
Q3 2021 | $2,420,000 | – | 500,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 3,275,616 | $8,746,000 | 1.82% |
Telemetry Investments, L.L.C. | 263,975 | $705,000 | 0.97% |
CHI Advisors LLC | 719,132 | $1,920,000 | 0.45% |
BVF INC/IL | 3,678,626 | $9,822,000 | 0.37% |
EcoR1 Capital, LLC | 3,579,377 | $9,557,000 | 0.36% |
Orbimed Advisors | 8,053,298 | $21,502,000 | 0.22% |
Stonepine Capital Management, LLC | 46,886 | $125,000 | 0.06% |
Ikarian Capital, LLC | 100,000 | $267,000 | 0.02% |
ALGERT GLOBAL LLC | 19,737 | $53,000 | 0.02% |
Windsor Creek Advisors, LLC | 14,786 | $39,000 | 0.01% |